Could stem cells help people with spinocerebellar ataxia?
NCT ID NCT07467733
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether stem cells and their exosomes (tiny particles that help cells communicate) can safely improve movement in people with spinocerebellar ataxia, a condition that affects coordination and balance. Ninety participants will receive the treatment through an IV and a nasal spray. The study focuses on safety and whether it can reduce symptoms like tremors and unsteady walking.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
neuroinduced mesenchymal stem cells and exosomes
What this could lead to
If it works, this could point toward a new treatment to improve motor function and slow progression of spinocerebellar ataxia.
What could go wrong
This is an early Phase I/II trial with only 90 participants, so results may not confirm effectiveness. Risks include unknown side effects from stem cell and exosome infusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BioCells Medical
Warsaw, 02-797, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••